If the findings are confirmed in larger studies, the scientists believe the microbubble transit may potentially serve as a marker of disease severity, or even a proxy endpoint in therapeutic trials for COVID-19 pneumonia. "Future studies that investigate the use of pulmonary vascular constrictors in this patient population may be warranted," Poor said.